X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (5) 5
index medicus (4) 4
aged (3) 3
clinical neurology (3) 3
male (3) 3
middle aged (3) 3
neurology (3) 3
disease duration (2) 2
female (2) 2
health-related quality of life (2) 2
medicine & public health (2) 2
neurosciences (2) 2
parkinson disease - drug therapy (2) 2
parkinson disease - physiopathology (2) 2
parkinson disease - therapy (2) 2
parkinson's disease (2) 2
quality of life (2) 2
tremor (2) 2
1103 clinical sciences (1) 1
1109 neurosciences (1) 1
a receptor antagonist (1) 1
abridged index medicus (1) 1
achievement behavior (1) 1
actigraphy (1) 1
adrenergic alpha-antagonists - therapeutic use (1) 1
adrenergic beta-antagonists - therapeutic use (1) 1
affect (1) 1
age (1) 1
aged, 80 and over (1) 1
analysis (1) 1
animals (1) 1
anticonvulsants - therapeutic use (1) 1
antiparkinson agents - administration & dosage (1) 1
antiparkinson agents - adverse effects (1) 1
antiparkinson agents - pharmacology (1) 1
article (1) 1
autogenic training (1) 1
basal ganglia - drug effects (1) 1
basal ganglia - physiopathology (1) 1
biomarkers - blood (1) 1
biomarkers - cerebrospinal fluid (1) 1
botulinum toxins - therapeutic use (1) 1
calcium channel blockers - therapeutic use (1) 1
carbonic anhydrase inhibitors - therapeutic use (1) 1
cholesterol (1) 1
clinical trials as topic (1) 1
cognitive ability (1) 1
comorbidity (1) 1
continuous dopaminergic stimulation (1) 1
corpus striatum - drug effects (1) 1
corpus striatum - physiopathology (1) 1
cross-sectional studies (1) 1
deep brain stimulation (1) 1
deep-brain-stimulation (1) 1
depression (1) 1
disability (1) 1
dopa-induced dyskinesias (1) 1
dopamine - metabolism (1) 1
dopamine - physiology (1) 1
dopamine agonists - adverse effects (1) 1
dopamine agonists - pharmacology (1) 1
double-blind (1) 1
double-blind method (1) 1
drug administration schedule (1) 1
drug therapy (1) 1
dyskinesia (1) 1
dyskinesia, drug-induced - etiology (1) 1
dyskinesia, drug-induced - physiopathology (1) 1
dyskinesia, drug-induced - prevention & control (1) 1
dyskinesia, drug-induced - psychology (1) 1
dyskinesia, drug-induced - therapy (1) 1
electric stimulation therapy (1) 1
epidemiology (1) 1
essential tremor - diagnosis (1) 1
essential tremor - drug therapy (1) 1
essential tremor - surgery (1) 1
essential tremor - therapy (1) 1
excitatory amino acid antagonists - therapeutic use (1) 1
family medical history (1) 1
feasibility studies (1) 1
follow-up studies (1) 1
gamma-aminobutyric acid - physiology (1) 1
health aspects (1) 1
hospitals (1) 1
humanities (1) 1
hypnosis - methods (1) 1
impact (1) 1
index (1) 1
inosine - therapeutic use (1) 1
inventory (1) 1
journal of parkinsonism and restless legs syndrome (1) 1
laboratories (1) 1
levodopa (1) 1
levodopa - administration & dosage (1) 1
levodopa - adverse effects (1) 1
levodopa - pharmacology (1) 1
long-term treatment (1) 1
management (1) 1
medical research (1) 1
medicine, experimental (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European Neurology, ISSN 0014-3022, 07/2008, Volume 60, Issue 2, pp. 57 - 66
Levodopa is the most effective agent to alleviate motor dysfunction in Parkinson's disease but its long-term use is associated with the development of... 
Parkinson's disease | Treatment | Levodopa | Management | Dyskinesia | Quality of life | treatment | SUBTHALAMIC NUCLEUS STIMULATION | CONTINUOUS DOPAMINERGIC STIMULATION | DOPA-INDUCED DYSKINESIAS | RANDOMIZED CONTROLLED-TRIAL | dyskinesia | NEUROSCIENCES | CLINICAL NEUROLOGY | MOTOR FLUCTUATIONS | levodopa | management | DOUBLE-BLIND | A(2A) RECEPTOR ANTAGONIST | DEEP-BRAIN-STIMULATION | PLACEBO-CONTROLLED TRIAL | quality of life | LONG-TERM TREATMENT | Parkinson Disease - therapy | Excitatory Amino Acid Antagonists - therapeutic use | Antiparkinson Agents - pharmacology | Dyskinesia, Drug-Induced - physiopathology | Dyskinesia, Drug-Induced - psychology | Humans | Dopamine Agonists - adverse effects | Dyskinesia, Drug-Induced - prevention & control | Parkinson Disease - drug therapy | gamma-Aminobutyric Acid - physiology | Multicenter Studies as Topic | Levodopa - administration & dosage | Dopamine - physiology | Deep Brain Stimulation | Dyskinesia, Drug-Induced - etiology | Severity of Illness Index | Dopamine Agonists - pharmacology | Levodopa - pharmacology | Parkinson Disease - complications | Corpus Striatum - physiopathology | Drug Administration Schedule | Basal Ganglia - physiopathology | Antiparkinson Agents - adverse effects | Dyskinesia, Drug-Induced - therapy | Animals | Levodopa - adverse effects | Corpus Striatum - drug effects | Quality of Life | Aged | Antiparkinson Agents - administration & dosage | Receptors, Glutamate - physiology | Basal Ganglia - drug effects | Index Medicus
Journal Article
JAMA Neurology, ISSN 2168-6149, 02/2014, Volume 71, Issue 2, pp. 141 - 150
Journal Article
The International journal of clinical and experimental hypnosis, ISSN 0020-7144, 4/2013, Volume 61, Issue 2, pp. 172 - 182
Parkinson’s disease is a severe neurodegenerative disorder with a prevalence rate of approximately 1.6% in elderly Americans. This case study reports on a... 
Journal Article
International Journal of Clinical and Experimental Hypnosis, ISSN 0020-7144, 04/2013, Volume 61, Issue 2, pp. 172 - 182
Journal Article
Journal of Clinical Neuroscience, ISSN 0967-5868, 06/2016, Volume 28, pp. 102 - 106
Health related quality of life (HRQoL) is negatively impacted in patients suffering from Parkinson's disease (PD). For the specific components that comprise... 
Disease duration | Health-related quality of life | Parkinson's disease | IMPACT | PEOPLE | NEUROSCIENCES | CLINICAL NEUROLOGY | Cross-Sectional Studies | Time Factors | Humans | Middle Aged | Aged, 80 and over | Quality of Life | Female | Male | Aged | Parkinson Disease - physiopathology | Medicine, Experimental | Medical research | Neurosciences | Analysis | Samhällsvetenskap | Social Sciences | Psychology | Psykologi
Journal Article
Journal of Clinical Neuroscience, ISSN 0967-5868, 2015, Volume 28, pp. 102 - 106
Highlights • Parkinson’s disease impacts multiple facets of quality of life (QOL). • Duration of illness is associated with worse QOL. • Some facets of QOL,... 
Neurology | Disease duration | Health-related quality of life | Parkinson’s disease
Journal Article
Journal of Parkinsonism and Restless Legs Syndrome, ISSN 1927-7733, 10/2015, Volume 5, Issue default, pp. 33 - 38
Introduction: Restless legs syndrome (RLS) is a chronic sensorimotor disorder characterized by discomfort or pain, predominantly in the legs, resulting in an... 
Comorbidity | Laboratories | Parkinsons disease | Cognitive ability | Family medical history | Patients | Epidemiology | Variance analysis | Sleep deprivation | Restless legs syndrome | Hospitals | Standard deviation | Inventory | Age
Journal Article
European Neurology, ISSN 0014-3022, 07/2008, Volume 60, Issue 2, pp. 57 - 66
Levodopa is the most effective agent to alleviate motor dysfunction in Parkinson’s disease but its long-term use is associated with the development of... 
Review
Journal Article
2005, Current Clinical Neurology, ISBN 9781588293312
Approaches to the pharmacotherapy of the “atypical” parkinsonian or “Parkinson plus” disorders have, as yet, met with little success. Drugs attempting to... 
Neurology | Medicine & Public Health
Book Chapter
01/2003, ISBN 9780203912164
Book Chapter
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.